CIK 0001570562
- Accelerated filer
Evolus, Inc.
Sign in to watch- Ticker
- EOLS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 461385614
- Phone
- +1 949-284-4555
- Business address
- 520 NEWPORT CENTER DRIVE, SUITE 1200, NEWPORT BEACH, CA, 92660
- Former names
- Evolus, Inc.
- 4 Grant or award MOATAZEDI DAVID acquired 214,286 shares (grant or award)
- 4 Grant or award SILVERNAIL LAUREN P acquired 53,571 shares (grant or award)
- 4 Grant or award Avelar Rui acquired 53,571 shares (grant or award)
- 4 Grant or award Chief Marketing Officer acquired 50,000 shares (grant or award)
- 4 Grant or award Director acquired 15,568 shares (grant or award)
- 4 Grant or award Director acquired 15,568 shares (grant or award)
- 4 Grant or award Director acquired 15,568 shares (grant or award)
- 4 Grant or award Director acquired 15,568 shares (grant or award)
- 4 Grant or award Director acquired 15,568 shares (grant or award)
- 4 Grant or award Director acquired 15,568 shares (grant or award)
- 4 Grant or award Director acquired 36,508 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale 10% owner sold 2,597,475 shares at $9.50 ($24,676,013)
- 4 Open-market buy 10% owner bought 51,000 shares at $10.93 ($557,568)
- 4 Open-market buy 10% owner bought 110,000 shares at an average $11.06 ($1,216,791)
- 4 Open-market sale Director sold 26,077 shares at $11.00 ($286,722)
- 4 Open-market buy 10% owner bought 142,000 shares at an average $11.10 ($1,576,808)
- 4 Open-market buy 10% owner bought 103,000 shares at an average $10.53 ($1,084,808)
- 4 Open-market sale Director sold 61,840 shares at an average $10.59 ($654,871)
- 4 Open-market sale Director sold 67,083 shares at an average $10.20 ($684,561)
Page 7 of 13 · 252 filings